Latest News

Shaping the Future of Precision Oncology

Follow the latest developments at Prevision Medicine — from strategic partnerships and scientific breakthroughs to company announcements and innovations transforming personalized cancer care.

March 4, 2026

Press Release: Prevision Medicine adds Multiple Myeloma to their personalized drug-testing portfolio

Prevision Medicine has expanded its personalized drug screening platform, PrevisionOne™, to include Multiple Myeloma (MM). The test generates patient-specific drug sensitivity profiles from patient samples, helping oncologists identify the most effective treatment combinations.

Read Article

October 31, 2025

Prevision Medicine joins the Genolier Innovation Network

Prevision Medicine has joined the Genolier Innovation Network, a collaborative ecosystem driving disruptive health innovations. This partnership will foster new opportunities to advance precision oncology and accelerate the future of personalized patient care.

Read Article

December 5, 2025

From Prototypes to Impact: Lessons from FutureHealth Lausanne

Two weeks ago, we attended FutureHealth Lausanne - one Europe’s leading conferences on healthcare innovation and digital transformation. Here are the three key insights we took away and what they mean for us at Prevision Medicine.

Read Article

December 5, 2025

Prevision Medicine launches Breakthrough Drug Screening Test for AML

Prevision Medicine today announced the clinical launch of its AML Drug Screening Test. The test is designed to help oncologists rapidly identify the most effective therapies for patients with acute myeloid leukemia (AML).

Read Article

View the News!

View our latest news updates directly on LinkedIn